Category: Pharmaceuticals
The move sets UK as the only European country to approve TIV High Dose for the prevention of influenza flu specifically amongst senior citizens. The UK has reportedly granted marketing authorization to vaccine maker Sanofi Pasteur’s TIV (Trivalent Influenza Vaccine) High Dose, a vaccine prescribed …
Imatinib Mesylate is claimed to stop the growth of cancer cells and is prescribed for treating Leukemia and certain Gastro-Intestinal tumors. Renowned pharmaceutical and biotechnology company, Wockhardt, recently received the USFDA approval for an ANDA for 100 mg and 400 mg tablets of Imatinib Mesylate. …
The Naloxone drug is predominantly used across emergency rooms in the U.S. to treat life-threatening opioid overdoses. FDA’s change clears the way for pharmaceutical companies to sell Naloxone without a prescription. The U.S. Food & Drug Administration (FDA), has reportedly announced that it would be …
The acquisition will offer customers with well-reputed and advanced eye care operations and ambulatory surgery centers in the Upstate area. Renowned eye care practice management firm, Eye Health America (EHA) has recently announced its acquisition of Donelson Eye Associates in Greenville, South Carolina. Reportedly, the …
The study shows improvement in PFS in patients treated with metastatic gastric cancer therapy varlitinib. Renowned clinical-stage biopharmaceutical firm, ASLAN Pharmaceuticals has recently announced an update on the global placebo-controlled phase 2 clinical study of varlitinib, as first-line therapy in metastatic gastric cancer patients, while …
The American company will be paying millions to CytoReason for its unparalleled models. CytoReason, the Israel based machine learning company, that is credited for developing immune system cell-centered models that necessarily aid in drug discovery, recently entered a collaboration with American pharmaceutical corporation, Pfizer Inc. …
The Canadian cannabis firm Aphria Inc. has reportedly revealed to have concluded the acquisition of a major Germany-based importer and distributor of pharmaceutical products, CC Pharma GmbH. As per trusted sources, Aphria Inc. has paid €18.92 million in cash to the former stakeholders of CC …
Pharmaceutical major Lupin has made it to the headlines upon attaining the approval from the U.S. Food and Drug Administration for selling its Lurasidone Hydrochloride tablets, used to treat schizophrenia, in the American market. The approved product is a generic form of Sunovion Pharmaceuticals’ Latuda …
In a recent turn of events, Merck & NGM Biopharmaceuticals Inc. jointly declared that Merck is reportedly exercising its options to license its NGM313 drug that is presently being examined for treating nonalcoholic steatohepatitis as well as type 2 diabetes. As per trusted sources, this …